Elon's Vision
  • Contacts
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Elon's Vision
No Result
View All Result
Home Investing

Healsgood AI raises £2.5m to scale NHS cost-saving platform Flexzo AI, bringing seed funding to £5m

by
October 3, 2025
in Investing
0
Healsgood AI raises £2.5m to scale NHS cost-saving platform Flexzo AI, bringing seed funding to £5m
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Healsgood AI, the healthtech behind Flexzo AI, has secured an additional £2.5 million in seed funding from Octopus Ventures, taking total investment in its NHS workforce management platform to £5 million over the past year.

The London-based company, which trades as Flexzo AI, is developing an artificial intelligence-driven system to help NHS Trusts and Integrated Care Boards (ICBs) cut their reliance on costly agency and bank staffing. Demand from NHS organisations has surged, prompting the fresh funding, which will support onboarding of new customers and further R&D.

This round builds on earlier backing from Fuel Ventures (£1.5m) and more than £1m from angel investors, reflecting growing confidence in Flexzo AI’s mission to modernise workforce management in the health service.

Tackling NHS staffing costs with AI

The NHS spends billions each year on temporary staff, with agency costs a persistent challenge for Trusts. Flexzo AI’s platform uses advanced AI infrastructure to enable hospitals to run their own staff banks, standardise pay rates, and optimise workforce planning.

By replacing traditional outsourcing models, Flexzo AI says its solution can deliver workforce management at a fraction of the cost, while improving transparency and conditions for frontline clinicians.

Jack Henderson, Founder and CEO of Healsgood AI, said: “The NHS has faced years of spiralling bank and agency costs. At Flexzo AI, we’re building the digital infrastructure that allows the NHS to own and manage its workforce sustainably. With Octopus Ventures, Fuel Ventures, and our angel investors behind us, we’re in a strong position to scale solutions that can save the NHS millions.”

Uthish Ranjan, Partner at Octopus Ventures, added: “Flexzo AI is addressing one of the NHS’s most urgent challenges — controlling staffing costs — with strong demand already coming from Trusts. We’re delighted to support the team as they build towards a more efficient, sustainable healthcare system.”

Shiv Patel, Partner at Fuel Ventures, said the company’s mix of “deep sector expertise and cutting-edge AI” positioned it to deliver “enormous value” to the health system.

With the NHS under financial pressure, Flexzo AI’s model aims to support both cost control and improved workforce sustainability. The company plans to expand its reach across Trusts nationwide, with longer-term ambitions to extend its technology into broader healthcare workforce and resource planning.

Read more:
Healsgood AI raises £2.5m to scale NHS cost-saving platform Flexzo AI, bringing seed funding to £5m

Previous Post

UK firms hit record levels of late invoice payments, leaving SMEs £109bn out of pocket

Next Post

Mone hits back at Kemi Badenoch in scathing letter: “what exactly have I done wrong?”

Next Post
Mone hits back at Kemi Badenoch in scathing letter: “what exactly have I done wrong?”

Mone hits back at Kemi Badenoch in scathing letter: “what exactly have I done wrong?”

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest

Jay Bhattacharya on Public Health

October 12, 2021

That Bangladesh Mask Study!

December 1, 2021

Antitrust Regulation Assumes Bureaucrats Know the “Correct” Amount of Competition

November 24, 2021
Pints of champagne could be the next ‘Brexit dividend’

Pints of champagne could be the next ‘Brexit dividend’

December 24, 2021
HMRC has stepped up its campaign to expand the scope of ‘confectionery’ under VAT law – and the courts are backing them.

HMRC has stepped up its campaign to expand the scope of ‘confectionery’ under VAT law – and the courts are backing them.

0

0

0

0
HMRC has stepped up its campaign to expand the scope of ‘confectionery’ under VAT law – and the courts are backing them.

HMRC has stepped up its campaign to expand the scope of ‘confectionery’ under VAT law – and the courts are backing them.

October 3, 2025
Friday Feature: School of Hope

Friday Feature: School of Hope

October 3, 2025
Trump’s crypto wallet rebounds 36% in Q3, but remains 70% down in 2025

Trump’s crypto wallet rebounds 36% in Q3, but remains 70% down in 2025

October 3, 2025

Jefferson’s War on the Barbary Pirates Is an Unjustified Password for Military Intervention

October 3, 2025

Recent News

HMRC has stepped up its campaign to expand the scope of ‘confectionery’ under VAT law – and the courts are backing them.

HMRC has stepped up its campaign to expand the scope of ‘confectionery’ under VAT law – and the courts are backing them.

October 3, 2025
Friday Feature: School of Hope

Friday Feature: School of Hope

October 3, 2025
Trump’s crypto wallet rebounds 36% in Q3, but remains 70% down in 2025

Trump’s crypto wallet rebounds 36% in Q3, but remains 70% down in 2025

October 3, 2025

Jefferson’s War on the Barbary Pirates Is an Unjustified Password for Military Intervention

October 3, 2025

Disclaimer: ElonsVision.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • Contacts
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 ElonsVision. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 ElonsVision. All Rights Reserved.